Anika Therapeutics Inc

Research Anika Therapeutics Inc (ANIK) on Bullrun: market cap USD 199.72M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerANIK
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 199.72M
• Financial periodFY2025
• RevenueUSD 112.82M
• Revenue growth-5.9%
• Net income-USD 11.00M
• Free cash flowUSD 4.36M
• Gross margin56.6%

Valuation Snapshot

latest market cap is USD 199.72M.

About Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product;

Frequently asked questions

What is Anika Therapeutics Inc's market cap?

Anika Therapeutics Inc's market capitalization is USD 199.72M.

What does Anika Therapeutics Inc do?

Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally.